Last month, Financial Secretary Paul Chan Mo-po announced an extra HK$400 million of recurrent funding would be injected into the authority to expand the scope of its formulary. Photo: Felix Wong

Expensive drug to treat rare genetic disease tuberous sclerosis complex to be available for HK$15 in Hong Kong – but prescription restriction means few will benefit

  • Everolimus, which costs HK$230,000 per patient and can reduce tumour sizes and frequency of seizures, added to Hospital Authority’s formulary from April
  • But under existing protocols, drug is given to patients with tumours exceeding 3cm in width and most in Hong Kong would not meet that requirement
Topic |   Drugs

TOP PICKS

Last month, Financial Secretary Paul Chan Mo-po announced an extra HK$400 million of recurrent funding would be injected into the authority to expand the scope of its formulary. Photo: Felix Wong
READ FULL ARTICLE